RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Dian Diagnostics Group Co - Stock

Dian Diagnostics Group Co Stocks 2024

Dian Diagnostics Group Co Stocks

626.92 M

Ticker

300244.SZ

ISIN

CNE1000015N1

In 2024, Dian Diagnostics Group Co had 626.92 M outstanding stocks, a 0% change from the 626.92 M stocks in the previous year.

The Dian Diagnostics Group Co Stocks history

YEARNUMBER OF STOCKS (undefined CNY)
2026e626.92
2025e626.92
2024e626.92
2023626.92
2022624.02
2021620.46
2020620
2019620
2018620
2017551
2016550
2015486
2014486
2013480
2012476
2011476
2010476
2009476
2008476

Dian Diagnostics Group Co shares outstanding

The number of shares was Dian Diagnostics Group Co in 2023 — This indicates how many shares 626.924 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Dian Diagnostics Group Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Dian Diagnostics Group Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Dian Diagnostics Group Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Dian Diagnostics Group Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Dian Diagnostics Group Co Aktienanalyse

What does Dian Diagnostics Group Co do?

Dian Diagnostics Group Co Ltd is one of the leading diagnostic companies in China, headquartered in Beijing. The company was founded in 1994 and has since become a major provider of healthcare services in the field of medical diagnostics. The business model of Dian Diagnostics Group Co Ltd focuses on providing diagnostic services and products to clinical laboratories, hospitals, and specialists. The company offers a wide range of products and services, such as laboratory equipment, diagnostic systems, and consumables. Dian Diagnostics Group Co Ltd operates in several business areas: 1. Clinical laboratory diagnostics: This business area focuses on conducting laboratory tests to make medical diagnoses. The tests performed in the laboratories of Dian Diagnostics Group Co Ltd include blood tests, urine analyses, imaging, and other medical tests. 2. Diagnostic systems and equipment: The company offers a wide range of diagnostic systems and equipment, such as blood analyzers, ultrasound devices, digital radiography (DR), and other medical devices. These products are used by medical professionals and hospitals and rely on high accuracy and quality. 3. Consumables: Dian Diagnostics Group Co Ltd also produces and supplies a wide range of consumables, including disposable syringes, needles, disposable gloves, and other medical instruments. 4. Medical educational materials: In addition to the above-mentioned business areas, the company also produces educational materials. These materials are specifically targeted towards medical professionals and students to help them expand their knowledge. It should be noted that the company has also played a major role in the fight against the COVID-19 pandemic in China in recent years. The company has produced a wide range of test kits and other medical devices and consumables to contribute to more effective diagnosis and treatment of COVID-19 infections. The company has a strong focus on research and development (R&D) and operates several R&D sites in China. This allows Dian Diagnostics Group Co Ltd to constantly improve their products and services and respond to the changing needs of customers. Overall, Dian Diagnostics Group Co Ltd is a major player in the diagnostics field in China and beyond. The company offers a wide range of products and services to help medical professionals and customers in the healthcare industry streamline their work, achieve higher accuracy in their diagnoses, and improve patient outcomes. Dian Diagnostics Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Dian Diagnostics Group Co's Shares Outstanding

Dian Diagnostics Group Co's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Dian Diagnostics Group Co’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Dian Diagnostics Group Co’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Dian Diagnostics Group Co’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Dian Diagnostics Group Co Stock

How many stocks are there of Dian Diagnostics Group Co?

The current number of stocks of Dian Diagnostics Group Co is 626.92 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Dian Diagnostics Group Co are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Dian Diagnostics Group Co evolved in recent years?

The number of shares of Dian Diagnostics Group Co has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Dian Diagnostics Group Co as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Dian Diagnostics Group Co?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Dian Diagnostics Group Co pay?

Over the past 12 months, Dian Diagnostics Group Co paid a dividend of 0.2 CNY . This corresponds to a dividend yield of about 1.66 %. For the coming 12 months, Dian Diagnostics Group Co is expected to pay a dividend of 0.24 CNY.

What is the dividend yield of Dian Diagnostics Group Co?

The current dividend yield of Dian Diagnostics Group Co is 1.66 %.

When does Dian Diagnostics Group Co pay dividends?

Dian Diagnostics Group Co pays a quarterly dividend. This is distributed in the months of August, July, July, June.

How secure is the dividend of Dian Diagnostics Group Co?

Dian Diagnostics Group Co paid dividends every year for the past 15 years.

What is the dividend of Dian Diagnostics Group Co?

For the upcoming 12 months, dividends amounting to 0.24 CNY are expected. This corresponds to a dividend yield of 1.96 %.

In which sector is Dian Diagnostics Group Co located?

Dian Diagnostics Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Dian Diagnostics Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Dian Diagnostics Group Co from 5/31/2023 amounting to 0.2 CNY, you needed to have the stock in your portfolio before the ex-date on 5/31/2023.

When did Dian Diagnostics Group Co pay the last dividend?

The last dividend was paid out on 5/31/2023.

What was the dividend of Dian Diagnostics Group Co in the year 2023?

In the year 2023, Dian Diagnostics Group Co distributed 0.135 CNY as dividends.

In which currency does Dian Diagnostics Group Co pay out the dividend?

The dividends of Dian Diagnostics Group Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Dian Diagnostics Group Co

Our stock analysis for Dian Diagnostics Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Dian Diagnostics Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.